Calendar aTyr Pharma, Inc. Deutsche Boerse AG

Equities

471A

US0021202025

Real-time Estimate Tradegate 04:30:06 18/06/2024 pm IST 5-day change 1st Jan Change
1.625 EUR -4.41% Intraday chart for aTyr Pharma, Inc. -7.43% +25.58%

Chart calendar aTyr Pharma, Inc.

ff8f876c6d3e99c2cd0f83c52a.OSef9fyhzw8gDqn5yMnsPBb4IKfIVjLCt6hVVXG-61k.WlLNo8qVv30NOdG6-ZuWWUPIbPKlAh_zzcIdITz7iBxdZsrNr8CVdUFjyg~dc326ed070c103b9abc6a97b9aa88106

Upcoming events on aTyr Pharma, Inc.

14/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on aTyr Pharma, Inc.

06/06/2024 02:00 am Jefferies Global Healthcare Conference
23/05/2024 10:15 pm Piper Sandler Virtual Lung Investor Day Conference - Fireside Chat
22/05/2024 Annual General Meeting
20/05/2024 02:45 am American Thoracic Society International Conference - Poster Number: 8837
15/05/2024 05:30 pm RBC Capital Markets Global Healthcare Conference - Fireside Chat
03/05/2024 01:30 am Q1 2024 Earnings Release
17/04/2024 Piper Sandler Spring Biopharma Symposium
04/04/2024 08:00 pm Evercore ISI Diamonds in the Rough Webinar Day
24/03/2024 Fibroblast Growth Factors in Development and Disease Gordon Research Conference
15/03/2024 02:30 am Q4 2023 Earnings Call
15/03/2024 01:30 am Q4 2023 Earnings Release
31/01/2024 08:00 am Keystone Symposium - Poster No: 2027
30/01/2024 09:00 am Keystone Symposium - Poster No: 1012
04/12/2023 Noble Capital Markets Emerging Growth Equity Conference
30/11/2023 10:30 pm Piper Sandler Healthcare Conference - Fireside Chat
15/11/2023 09:00 pm Jefferies London Healthcare Conference
13/11/2023 10:30 pm American College of Rheumatology Conference - Poster Number: 1322
09/11/2023 Q3 2023 Earnings Release
13/09/2023 07:00 pm H.C. Wainwright Global Investment Conference
09/09/2023 European Respiratory Society International Congress

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,42
0,43
-2.26%
10,5
8,53
22.52%
0,00
2,52
-
10,4
0,25
4054.4%
0,35
0,41
-14.28%

0,30

EBITDA
Million USD
Released
Forecast
Spread
-22,3
-22,9
2.43%
-15,3
-17,8
13.81%
-33,5
-34,9
3.9%
-46,2
-52,2
11.55%
0,00
-53,7
-

-71,7

EBIT
Million USD
Released
Forecast
Spread
-23,0
-22,9
-0.39%
-15,9
-19,1
16.58%
-34,0
-33,6
-1.26%
-46,4
-52,5
11.57%
-54,9
-53,2
-3.29%

-66,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-23,8
-23,3
-1.99%
-16,2
-19,4
16.34%
-33,8
-32,8
-3.07%
-45,3
-51,7
12.3%
-50,4
-49,5
-1.89%

-64,0

Net income
Million USD
Released
Forecast
Spread
-23,6
-23,3
-1.3%
-16,2
-19,4
16.37%
-33,8
-32,8
-3.06%
-45,3
-51,7
12.31%
-50,4
-49,5
-1.89%

-64,1

EPS
USD
Released
Forecast
Spread
-7,03
-6,98
-0.72%
-1,77
-2,17
18.31%
-1,77
-1,79
1.3%
-1,60
-1,82
12.09%
-0,94
-0,93
-0.64%

-0,93

Announcement Date26/03/2023/03/2114/03/2209/03/2314/03/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
8,25
8,14
1.35%
0,00
0,17
-
0,00
2,00
-
0,00
0,40
-
10,4
0,25
4054.4%
0,00
0,36
-
0,00
0,61
-
0,35
1,20
-70.58%
0,00
0,05
-
0,24
0,02
968.18%

0,02


0,03


0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread
-4,15
-4,30
3.49%
-12,3
-8,80
-39.74%
-12,5
-10,3
-21.56%
-13,5
-12,7
-6.24%
-7,91
-13,8
42.67%
-12,7
-13,5
5.87%
-13,4
-11,1
-20.69%
-12,4
-10,0
-24.39%

-16,4

-16,5
-16,8
2.04%

-17,6


-18,3


-19,2







EBIT
Million USD
Released
Forecast
Spread



-12,4
-8,84
-39.96%
-12,6
-11,1
-13.88%
-13,5
-13,4
-0.81%
-7,95
-14,0
43.33%
-12,8
-16,4
22.21%
-13,6
-13,3
-2.19%
-12,6
-14,2
11.42%
-16,0
-13,7
-16.87%
-16,6
-16,2
-2.89%

-16,2


-16,1


-16,4


-11,5


-11,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-4,70
-4,30
-9.3%
-12,2
-8,75
-38.94%
-12,4
-12,4
-0.23%
-13,2
-13,1
-1.45%
-7,52
-13,9
45.83%
-12,0
-15,6
23.42%
-12,3
-12,6
1.81%
-11,3
-12,6
10.13%
-14,8
-13,9
-6.02%
-15,5
-15,6
0.94%

-15,9


-16,0


-16,4


-11,5


-11,4

Net income
Million USD
Released
Forecast
Spread
-4,69
-4,30
-9.07%
-12,2
-8,75
-38.94%
-12,4
-12,4
-0.23%
-13,2
-13,1
-1.45%
-7,52
-13,9
45.84%
-12,0
-15,6
23.42%
-12,3
-12,6
1.84%
-11,3
-12,6
10.13%
-14,8
-13,9
-6.02%
-15,5
-15,6
0.91%

-15,9


-16,0


-16,4


-11,5


-11,4

EPS
USD
Released
Forecast
Spread
-0,58
-0,53
-9.43%
-0,44
-0,33
-32.66%
-0,44
-0,44
0%
-0,46
-0,46
0.54%
-0,26
-0,48
45.83%
-0,29
-0,41
29.61%
-0,22
-0,27
19.71%
-0,20
-0,22
10.11%
-0,25
-0,24
-5.04%
-0,23
-0,25
8%

-0,24


-0,24


-0,23


-0,16


-0,16

Announcement Date13/08/2009/05/2215/08/2210/11/2209/03/2309/05/2309/08/2309/11/2314/03/2402/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise